Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

CV Therapeutics seeks FDA approval of regadenoson for use in MPI

May 16, 2007

Azedra studied in phase I/II trial for malignant pheochromocytoma

May 14, 2007

RG-1068 shows utility in MRI imaging of the pancreas

May 14, 2007

In vivo imaging of primate brain with novel adenosine A2 receptor radioligand

May 8, 2007

Phase III trial finds Imagify non-inferior to nuclear stress

May 4, 2007

New generation of MRI contrast agents developed at Bracco

May 3, 2007

Novel diagnostic agents disclosed in recent Therapharm patent

April 16, 2007

Novel diagnostic agents imparted in recent patents

April 11, 2007

Utility of I-123 MIBG in diagnosis of neuroblastomas

March 30, 2007

Herpes simplex virus shows potential as a diagnostic tool for cancer

March 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...